Spectral Diagnostics (OTCMKTS:EDTXF) Announces Earnings Results

Spectral Diagnostics (OTCMKTS:EDTXF) issued its quarterly earnings data on Friday. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.07), Zacks reports. The company had revenue of $0.49 million for the quarter, compared to analyst estimates of $0.54 million.

Spectral Diagnostics Stock Performance

Shares of OTCMKTS:EDTXF opened at $1.02 on Friday. Spectral Diagnostics has a 52 week low of $0.32 and a 52 week high of $1.31. The firm has a market cap of $294.36 million, a PE ratio of -16.97 and a beta of 0.10. The firm’s fifty day moving average is $1.09 and its 200-day moving average is $0.80.

Spectral Diagnostics Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.